Management of Bupropion-Induced Bruxism
Reduce the bupropion dose to 150 mg once daily or switch to an alternative antidepressant, as bruxism is a dose-related dystonic adverse reaction to bupropion that typically resolves with dose reduction. 1
Immediate Management Strategy
Lower the bupropion dose first before considering other interventions. A case report demonstrates that bupropion-induced jaw clenching and temporomandibular symptoms resolved within 24–48 hours when the dose was reduced from 300 mg daily (150 mg twice daily) to 150 mg once daily, with sustained symptom control for over one year at the lower dose. 1 This dose-response relationship suggests that many patients can continue bupropion therapy at a reduced dose without experiencing bruxism. 1
Pharmacologic Augmentation if Dose Reduction Is Insufficient
If reducing bupropion compromises antidepressant efficacy or if bruxism persists at lower doses, add buspirone 5 mg at bedtime. Although buspirone has been successfully used to treat SSRI-induced bruxism 2, one case report showed that buspirone 45 mg daily did not cause bruxism when used alone, even after the patient had developed dystonic symptoms on combined bupropion-buspirone therapy. 1 This suggests buspirone may be safe as an adjunct, though the evidence is limited and contradictory.
Alternatively, pregabalin 375 mg daily completely eliminated awake bruxism in a patient with generalized anxiety disorder who was also taking bupropion 300 mg daily. 3 The bruxism recurred twice when pregabalin was reduced, confirming a dose-dependent effect. 3 Pregabalin may be particularly useful if anxiety is a contributing factor, though this represents low-quality evidence from a single case report.
Alternative Antidepressant Options
If dose reduction fails and the patient requires full antidepressant dosing, switch to an SSRI such as escitalopram 10–20 mg daily or sertraline 50–200 mg daily. 4 These agents provide equivalent antidepressant efficacy to bupropion (remission rates 42–49%) 4, though they lack bupropion's specific advantages for low energy and carry higher rates of sexual dysfunction. 4
Mirtazapine 7.5–30 mg at bedtime is another well-tolerated alternative with minimal risk of movement-related side effects and can improve sleep. 5 Mirtazapine's antihistaminic properties reduce sympathetic drive, making dystonic reactions unlikely. 5
Mechanism and Clinical Context
Bupropion-induced bruxism represents a focal dystonia caused by dopaminergic and serotonergic system interactions. 1 Medication-induced dystonias typically present with jaw clenching, bruxism, and temporomandibular joint syndrome, usually within 24–48 hours of dose increases. 1 The rapid onset after dose escalation and resolution with dose reduction confirm a causal relationship. 1
Critical Safety Screening
Before attributing bruxism solely to bupropion, verify the patient does not have uncontrolled hypertension, as bupropion can elevate blood pressure and heart rate, which may independently contribute to muscle tension and jaw clenching. 4, 5 Monitor blood pressure, especially during the first 12 weeks of therapy. 4, 5
Monitoring Parameters
- Assess jaw pain, tooth damage, and headache severity weekly during dose adjustments 1
- Dental evaluation may be warranted if bruxism has been prolonged, as tooth wear and damage to dental restorations can occur 3
- If buspirone is added, monitor for resolution of symptoms within 4 days, as this was the timeframe for improvement in SSRI-induced bruxism 2
Common Pitfalls to Avoid
Do not continue bupropion at 300 mg daily if bruxism develops—the dystonic reaction is dose-dependent and will likely persist or worsen. 1 Do not add an SSRI to treat bruxism, as SSRIs themselves can cause bruxism and may compound the problem. 2 Do not assume bruxism will resolve spontaneously without dose adjustment, as one patient experienced sustained symptoms that only resolved with dose reduction. 1